Alexander Randolph Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.29M Sell
6,518
-60
-0.9% -$21.4K 1.98% 15
2025
Q4
$2.15M Hold
6,578
1.79% 15
2025
Q3
$1.86M Sell
6,578
-5
-0.1% -$1.45K 1.53% 18
2025
Q2
$1.84M Sell
6,583
-117
-2% -$33.1K 1.65% 18
2025
Q1
$2.09M Sell
6,700
-229
-3% -$67.6K 2.04% 15
2024
Q4
$1.81M Sell
6,929
-36
-0.5% -$10.7K 1.67% 20
2024
Q3
$2.24M Sell
6,965
-65
-0.9% -$21.3K 1.99% 19
2024
Q2
$2.2M Sell
7,030
-145
-2% -$42.6K 2.06% 18
2024
Q1
$2.04M Sell
7,175
-43
-0.6% -$12.6K 1.79% 21
2023
Q4
$2.08M Buy
+7,218
New +$1.97M 1.89% 21

Other funds holding AMGN

Alexander Randolph Advisory's AMGN Position: Q1 2026 in Review

Alexander Randolph Advisory reduced its Amgen (AMGN) stake by 0.91% in Q1 2026, selling an estimated $21.4K and leaving 6,518 shares worth $2.29M. The position accounts for 1.98% of the portfolio, ranked #15.

Alexander Randolph Advisory first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Alexander Randolph Advisory held 6,518 shares of Amgen worth $2.29M as of Q1 2026.
  • Alexander Randolph Advisory sold 60 Amgen shares in Q1 2026, an estimated $21.4K.
  • Amgen made up 1.98% of Alexander Randolph Advisory's portfolio in Q1 2026, its #15 holding.
  • Alexander Randolph Advisory first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Alexander Randolph Advisory's 13F filing for Q1 2026, filed 7 May 2026.